- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
U.S. Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
2
0 new
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
2 companies
Stoke Therapeutics
Market Cap: US$1.7b
An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.
STOK
US$31.21
7D
9.6%
1Y
162.0%
Theravance Biopharma
Market Cap: US$959.7m
A biopharmaceutical company, develops and commercializes medicines in the United States.
TBPH
US$19.96
7D
12.6%
1Y
111.9%